Lymphadenopathy other imaging findings: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Lymphadenopathy}} {{CMG}}; {{AE}} {{RT}} ==Overview== ==Other Imaging Studies== Positron emission tomography (PET) is used to evaluate clinically diagnos...") |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{RT}} | {{CMG}}; {{AE}} {{RT}} | ||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | |||
==Overview== | ==Overview== | ||
[[Positron emission tomography]] ([[PET]]) is used to evaluate clinically diagnosed [[lymphadenopathy]]. | [[Positron emission tomography]] ([[PET]]) is used to evaluate clinically diagnosed [[lymphadenopathy]]. | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:primary care]] | |||
[[Category:Inflammations]] | |||
[[Category:Dermatology]] | |||
[[Category:Signs and symptoms]] | |||
[[Category:Infectious disease]] | |||
[[Category:Hematology]] | |||
[[Category:Oncology]] | |||
[[Category:Physical examination]] | |||
[[Category:Needs content]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 17:01, 8 March 2013
|
Lymphadenopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Lymphadenopathy other imaging findings On the Web |
|
American Roentgen Ray Society Images of Lymphadenopathy other imaging findings |
|
Risk calculators and risk factors for Lymphadenopathy other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Positron emission tomography (PET) is used to evaluate clinically diagnosed lymphadenopathy.